BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30106327)

  • 1. Solubility enhancement and solid-state characterisation.
    Tobyn M
    Pharm Dev Technol; 2018 Sep; 23(7):663. PubMed ID: 30106327
    [No Abstract]   [Full Text] [Related]  

  • 2. Formulation and Stability of Solutions.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):41-5. PubMed ID: 27127830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
    Ellenberger DJ; Miller DA; Williams RO
    AAPS PharmSciTech; 2018 Jul; 19(5):1933-1956. PubMed ID: 29846889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formulation and special investigations of innovative intraoral solid dosage forms.].
    Kristo K; kATONA B; Piukovics P; Olah I; Sipos B; Sipos SE; Sovany T; Hodi K; Ifi Regdon G
    Acta Pharm Hung; 2016; 86(3):99-111. PubMed ID: 29489081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufacturing classification system (MCS): enabling better understanding of oral solid dosage formulation design.
    Leane M
    Pharm Dev Technol; 2024 Jun; 29(5):393-394. PubMed ID: 38738506
    [No Abstract]   [Full Text] [Related]  

  • 8. Interdependence of Dosage Form Microstructure and Performance.
    Axel Zeitler J; Rades T
    Pharm Res; 2017 May; 34(5):887-889. PubMed ID: 28299534
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.
    Palucki M; Higgins JD; Kwong E; Templeton AC
    J Med Chem; 2010 Aug; 53(16):5897-905. PubMed ID: 20527889
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA; Carrier RL; Ahmed I
    J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
    Peltonen L; Hirvonen J
    Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basics of Compounding with Dilutions and Concentrates.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):39-45. PubMed ID: 28346197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in techniques for enhancing the solubility of hydrophobic drugs.
    Xu Z; Lin S; Li Q; Jiang S; Wang P
    Pak J Pharm Sci; 2022 Jan; 35(1):95-112. PubMed ID: 35221278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic Principles of Lyophilization, Part 2.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):20-7. PubMed ID: 27125053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application research of hot-melt extrusion in preparation of solid dispersion].
    Chen MW; Chen WR; Chen TK; Chen RE; Wang YT
    Yao Xue Xue Bao; 2012 Feb; 47(2):163-7. PubMed ID: 22512025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot-melt extrusion.
    Jana S; Miloslava R
    Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of particle size decrease in the preformulation].
    Szunyogh T; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2011; 81(1):29-36. PubMed ID: 21595303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the production methods of orodispersible films.
    Musazzi UM; Khalid GM; Selmin F; Minghetti P; Cilurzo F
    Int J Pharm; 2020 Feb; 576():118963. PubMed ID: 31857185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.